Published in Toxicol Lett on June 23, 2010
Real time monitoring of biomaterial-mediated inflammatory responses via macrophage-targeting NIR nanoprobes. Biomaterials (2011) 0.98
Assessment of cytotoxicity of (N-isopropyl acrylamide) and poly(N-isopropyl acrylamide)-coated surfaces. Biointerphases (2013) 0.81
Release of anti-inflammatory peptides from thermosensitive nanoparticles with degradable cross-links suppresses pro-inflammatory cytokine production. Biomacromolecules (2015) 0.80
pH-Sensitive stimulus-responsive nanocarriers for targeted delivery of therapeutic agents. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2016) 0.78
Synthesis of a cell penetrating peptide modified superparamagnetic iron oxide and MRI detection of bladder cancer. Oncotarget (2016) 0.75
Synthesis and optimization of fluorescent poly(N-isopropyl acrylamide)-coated surfaces by atom transfer radical polymerization for cell culture and detachment. Biointerphases (2014) 0.75
Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A (2007) 7.50
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A (2008) 5.76
Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol (2012) 3.48
Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed Engl (2007) 3.41
Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol (2013) 3.39
Nucleation of protein fibrillation by nanoparticles. Proc Natl Acad Sci U S A (2007) 3.23
Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc (2011) 3.19
What the cell "sees" in bionanoscience. J Am Chem Soc (2010) 3.07
Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano (2012) 2.59
Protein-nanoparticle interactions: opportunities and challenges. Chem Rev (2011) 2.34
The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Adv Colloid Interface Sci (2007) 2.22
The evolution of the protein corona around nanoparticles: a test study. ACS Nano (2011) 2.05
Detecting cryptic epitopes created by nanoparticles. Sci STKE (2006) 2.02
Protein-nanoparticle interactions: What does the cell see? Nat Nanotechnol (2009) 2.00
In vitro toxicity evaluation of single walled carbon nanotubes on human A549 lung cells. Toxicol In Vitro (2006) 1.93
Resonant Mie scattering (RMieS) correction of infrared spectra from highly scattering biological samples. Analyst (2009) 1.92
Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population. Nat Nanotechnol (2011) 1.90
Inhibition of amyloid beta protein fibrillation by polymeric nanoparticles. J Am Chem Soc (2008) 1.60
Complete high-density lipoproteins in nanoparticle corona. FEBS J (2009) 1.47
Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. J Am Chem Soc (2013) 1.44
Quantification of nanoparticle uptake by cells using an unbiased sampling method and electron microscopy. Nanomedicine (Lond) (2011) 1.43
Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery". J Control Release (2012) 1.41
Structure-property relationships for electron-vibrational coupling in conjugated organic oligomeric systems. J Phys Chem B (2005) 1.40
Exposure assessment: recommendations for nanotechnology-based pesticides. Int J Occup Environ Health (2011) 1.39
Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices. Nanotoxicology (2010) 1.38
Systematic investigation of the thermodynamics of HSA adsorption to N-iso-propylacrylamide/N-tert-butylacrylamide copolymer nanoparticles. Effects of particle size and hydrophobicity. Nano Lett (2007) 1.37
Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines. PLoS One (2011) 1.36
Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona. ACS Nano (2012) 1.35
Experimental and theoretical comparison of intracellular import of polymeric nanoparticles and small molecules: toward models of uptake kinetics. Nanomedicine (2011) 1.35
Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials (2010) 1.34
Resonant Mie scattering in infrared spectroscopy of biological materials--understanding the 'dispersion artefact'. Analyst (2009) 1.31
Emerging methods and tools for environmental risk assessment, decision-making, and policy for nanomaterials: summary of NATO Advanced Research Workshop. J Nanopart Res (2008) 1.28
Reproducible comet assay of amorphous silica nanoparticles detects no genotoxicity. Nano Lett (2008) 1.25
Quantitative assessment of the comparative nanoparticle-uptake efficiency of a range of cell lines. Small (2011) 1.25
The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes. Nanomedicine (2013) 1.25
Time and space resolved uptake study of silica nanoparticles by human cells. Mol Biosyst (2010) 1.25
Fate and effects of CeO2 nanoparticles in aquatic ecotoxicity tests. Environ Sci Technol (2009) 1.20
Nanotoxicology: nanoparticles reconstruct lipids. Nat Nanotechnol (2009) 1.19
Gastroprotective effect of Neem (Azadirachta indica) bark extract: possible involvement of H(+)-K(+)-ATPase inhibition and scavenging of hydroxyl radical. Life Sci (2002) 1.18
Reactive oxygen species (ROS) induced cytokine production and cytotoxicity of PAMAM dendrimers in J774A.1 cells. Toxicol Appl Pharmacol (2010) 1.15
Dual effect of amino modified polystyrene nanoparticles on amyloid β protein fibrillation. ACS Chem Neurosci (2010) 1.14
Nanopesticides: guiding principles for regulatory evaluation of environmental risks. J Agric Food Chem (2014) 1.12
Therapeutic nanoparticles in clinics and under clinical evaluation. Nanomedicine (Lond) (2013) 1.11
Concern-driven integrated approaches to nanomaterial testing and assessment--report of the NanoSafety Cluster Working Group 10. Nanotoxicology (2013) 1.10
Surface-induced changes in protein adsorption and implications for cellular phenotypic responses to surface interaction. Biomaterials (2006) 1.10
Nanobiotechnology: nanoparticle coronas take shape. Nat Nanotechnol (2011) 1.09
Classification framework for graphene-based materials. Angew Chem Int Ed Engl (2014) 1.06
Medium from irradiated cells induces dose-dependent mitochondrial changes and BCL2 responses in unirradiated human keratinocytes. Radiat Res (2005) 1.04
A dose threshold for a medium transfer bystander effect for a human skin cell line. Radiat Res (2006) 1.03
Novel method to prepare morphologically rich polymeric surfaces for biomedical applications via phase separation and arrest of microgel particles. J Phys Chem B (2006) 1.03
Phase equilibria and glass transition in colloidal systems with short-ranged attractive interactions: application to protein crystallization. Phys Rev E Stat Nonlin Soft Matter Phys (2002) 1.03
A new approach to the toxicity testing of carbon-based nanomaterials--the clonogenic assay. Toxicol Lett (2007) 1.03
Raman spectroscopic evaluation of efficacy of current paraffin wax section dewaxing agents. J Histochem Cytochem (2005) 1.02
In vitro developmental toxicity test detects inhibition of stem cell differentiation by silica nanoparticles. Toxicol Appl Pharmacol (2009) 1.02
Nanomaterial categorization for assessing risk potential to facilitate regulatory decision-making. ACS Nano (2015) 1.01
Correlation signature of the macroscopic states of the gene regulatory network in cancer. Proc Natl Acad Sci U S A (2009) 1.01
Calcium fluxes modulate the radiation-induced bystander responses in targeted glioma and fibroblast cells. Radiat Res (2006) 1.01
Interaction of soft condensed materials with living cells: phenotype/transcriptome correlations for the hydrophobic effect. Proc Natl Acad Sci U S A (2003) 1.00
Protein fibrillation and nanoparticle interactions: opportunities and challenges. Nanoscale (2013) 1.00
Dispersion medium modulates oxidative stress response of human lung epithelial cells upon exposure to carbon nanomaterial samples. Toxicol Appl Pharmacol (2009) 1.00
Increased mitochondrial mass in cells with functionally compromised mitochondria after exposure to both direct gamma radiation and bystander factors. Radiat Res (2007) 0.99
Surface coatings shape the protein corona of SPIONs with relevance to their application in vivo. Langmuir (2012) 0.99
SWCNT suppress inflammatory mediator responses in human lung epithelium in vitro. Toxicol Appl Pharmacol (2008) 0.98
High-speed imaging of Rab family small GTPases reveals rare events in nanoparticle trafficking in living cells. ACS Nano (2012) 0.98
Activation of stress-related signalling pathway in human cells upon SiO2 nanoparticles exposure as an early indicator of cytotoxicity. J Nanobiotechnology (2011) 0.97
Reflection contributions to the dispersion artefact in FTIR spectra of single biological cells. Analyst (2009) 0.96
Growth substrate induced functional changes elucidated by FTIR and Raman spectroscopy in in-vitro cultured human keratinocytes. Anal Bioanal Chem (2006) 0.96
A new methodology for studying nanoparticle interactions in biological systems: dispersing titania in biocompatible media using chemical stabilisers. Nanoscale (2011) 0.96
Mechanistic studies of in vitro cytotoxicity of poly(amidoamine) dendrimers in mammalian cells. Toxicol Appl Pharmacol (2010) 0.94
Nanoscale reference materials for environmental, health and safety measurements: needs, gaps and opportunities. Nanotoxicology (2012) 0.94